Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| DOCS | Doximity, Inc. | 2025-10-30 19:16:08 | 65.73 | -0.09 | -0.14 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DOCS | 0001516513 | Doximity, Inc. | US26622P1075 | — | 272485512 | NYSE | 7371 | Services-Computer Programming Services | 0331 | DE | 500 THIRD STREET, SUITE 510 | SAN FRANCISCO | CA | 94107 | UNITED STATES | US | (650) 549-4330 | 500 THIRD STREET, SUITE 510, SAN FRANCISCO, CA, 94107 | 500 THIRD STREET, SUITE 510, SAN FRANCISCO, CA, 94107 | — | Internet | 2010 | Jeff Tangney | 827 | https://doximity.com | 5,650,000,000 | 187,453,000 | — | Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration. | 2025-10-30 12:47:24 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 5,650,000,000 | 3,090,000,000 | 120.7031 | — | — | — |
| 2024 | 2,560,000,000 | -1,070,000,000 | -29.4766 | — | — | — |
| 2023 | 3,630,000,000 | -5,370,000,000 | -59.6667 | — | — | — |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Nate Gross | Chief Strategy Officer | 2025 | 322,917 | — | 994,201 | 198,000 | 5,326 | 1,520,444 |
| Jennifer Chaloemtiarana | General Counsel | 2025 | 322,917 | — | 994,201 | 330,000 | 4,751 | 1,651,869 |
| Jeff Tangney | Chief Executive Officer | 2025 | 600,000 | — | 15,431,144 | 1,200,000 | 3,845 | 17,234,989 |
| Anna Bryson | Chief Financial Officer | 2025 | 400,000 | — | 0 | 421,296 | 4,098 | 825,394 |
| Nate Gross | Chief Strategy Officer | 2024 | 300,000 | — | 0 | 0 | 5,469 | 305,469 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 830 |
| 2024 | 827 |
| 2023 | 977 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 570,399,000 | 475,422,000 | 419,052,000 |
| Cost Of Revenue | 55,874,000 | 50,669,000 | 53,490,000 |
| Gross Profit | 514,525,000 | 424,753,000 | 365,562,000 |
| Research And Development Expenses | 93,038,000 | 81,983,000 | 80,186,000 |
| General And Administrative Expenses | 45,670,000 | 37,827,000 | 36,745,000 |
| Operating Expenses | 286,725,000 | 260,875,000 | 240,454,000 |
| Operating Income | 227,800,000 | 163,878,000 | 125,108,000 |
| Net Income | 223,185,000 | 147,582,000 | 112,818,000 |
| Earnings Per Share Basic | 1.19 | 0.78 | 0.58 |
| Earnings Per Share Diluted | 1.11 | 0.72 | 0.53 |
| Weighted Average Shares Outstanding Basic | 186,841,000 | 190,172,000 | 193,176,000 |
| Weighted Average Shares Outstanding Diluted | 201,208,000 | 205,734,000 | 213,425,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 209,614,000 | 96,785,000 | 158,027,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 128,354,000 | 101,332,000 | 107,047,000 |
| Inventories | — | — | — |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 1,088,620,000 | 912,941,000 | 975,453,000 |
| Marketable Securities Non Current | 243,417,000 | 123,259,000 | 315,629,000 |
| Property Plant And Equipment | 13,656,000 | 12,318,000 | 11,279,000 |
| Other Assets Non Current | 2,121,000 | 1,458,000 | 1,654,000 |
| Total Assets Non Current | 175,689,000 | 166,433,000 | 161,435,000 |
| Total Assets | 1,264,309,000 | 1,079,374,000 | 1,136,888,000 |
| Accounts Payable | 1,356,000 | 2,253,000 | 1,272,000 |
| Deferred Revenue | 114,285,000 | 99,145,000 | 105,238,000 |
| Short Term Debt | — | — | — |
| Other Liabilities Current | 38,405,000 | 43,703,000 | 31,245,000 |
| Total Liabilities Current | 156,257,000 | 147,250,000 | 139,507,000 |
| Long Term Debt | — | — | — |
| Other Liabilities Non Current | 9,383,000 | 7,224,000 | 1,240,000 |
| Total Liabilities Non Current | 25,427,000 | 30,727,000 | 31,265,000 |
| Total Liabilities | 181,684,000 | 177,977,000 | 170,772,000 |
| Common Stock | 189,000 | 187,000 | 194,000 |
| Retained Earnings | 186,888,000 | 79,989,000 | 217,855,000 |
| Accumulated Other Comprehensive Income | 1,323,000 | -2,664,000 | -14,083,000 |
| Total Shareholders Equity | 1,082,625,000 | 901,397,000 | 966,116,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 10,659,000 | 10,265,000 | 10,283,000 |
| Share Based Compensation Expense | 72,386,000 | 51,076,000 | 47,834,000 |
| Other Non Cash Income Expense | -270,000 | -1,230,000 | -1,454,000 |
| Change In Accounts Receivable | 27,206,000 | -3,993,000 | 26,242,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -663,000 | 8,332,000 | -195,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 273,265,000 | 184,096,000 | 179,602,000 |
| Purchases Of Marketable Securities | 675,557,000 | 472,867,000 | 190,560,000 |
| Sales Of Marketable Securities | 17,383,000 | 74,675,000 | 107,182,000 |
| Acquisition Of Property Plant And Equipment | 0 | 147,000 | 1,701,000 |
| Acquisition Of Business | 0 | 0 | 53,500,000 |
| Other Investing Activities | — | 0 | 0 |
| Cash From Investing Activities | -29,298,000 | 31,186,000 | -59,923,000 |
| Tax Withholding For Share Based Compensation | 27,185,000 | 6,756,000 | 3,822,000 |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 3,569,000 | 3,446,000 | 4,759,000 |
| Repurchase Of Common Stock | 120,293,000 | 280,716,000 | 85,324,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | 19,732,000 | 12,892,000 | 9,926,000 |
| Cash From Financing Activities | -131,138,000 | -276,524,000 | -74,461,000 |
| Change In Cash | 112,829,000 | -61,242,000 | 45,218,000 |
| Cash At End Of Period | 209,614,000 | 96,785,000 | 158,027,000 |
| Income Taxes Paid | 55,654,000 | 51,274,000 | 5,231,000 |
| Interest Paid | — | — | — |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 1.19 | 0.78 | 0.58 |
| Price To Earnings Ratio | 48.7647 | 33.859 | 55.8276 |
| Earnings Growth Rate | 52.5641 | 34.4828 | -29.2683 |
| Price Earnings To Growth Ratio | 0.9277 | 0.9819 | -1.9074 |
| Book Value Per Share | 5.7944 | 4.7399 | 5.0012 |
| Price To Book Ratio | 10.0149 | 5.5718 | 6.4744 |
| Ebitda | 289,498,000 | 209,121,000 | 128,332,000 |
| Enterprise Value | — | — | — |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | — | — | — |
| Capital Expenditures | 11,997,000 | 11,304,000 | 13,074,000 |
| Free Cash Flow | 261,268,000 | 172,792,000 | 166,528,000 |
| Return On Equity | 0.2062 | 0.1637 | 0.1168 |
| One Year Beta | 1.2086 | 1.6424 | 1.6261 |
| Three Year Beta | 1.5278 | 1.658 | 1.6689 |
| Five Year Beta | 1.5757 | 1.658 | 1.6689 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Benjamin Regina M. | Director | 2025-10-10 | 5,000 | A | 24,839 |
| Benjamin Regina M. | Director | 2025-10-10 | 5,000 | D | 19,839 |
| Benjamin Regina M. | Director | 2025-10-10 | 5,000 | D | 351,138 |
| Benjamin Regina M. | Director | 2025-10-10 | 5,000 | A | 5,000 |
| Benjamin Regina M. | Director | 2025-10-10 | 5,000 | D | 0 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Jonathan Jackson | 2025-09-23 | IL01 | Purchase | 2025-08-25 | Joint | $15,001 - $50,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| TEACHER RETIREMENT SYSTEM OF TEXAS | 2025-09-30 | 3,824,796 | 52,287 | 73.15 |
| Parkside Financial Bank & Trust | 2025-09-30 | 44,111 | 603 | 73.1526 |
| STRS OHIO | 2025-09-30 | 233,495 | 3,192 | 73.1501 |
| Aubrey Capital Management Ltd | 2025-09-30 | 4,572,188 | 62,500 | 73.155 |
| Covestor Ltd | 2025-09-30 | 15,000 | 204 | 73.5294 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| SHELTON FUNDS | 2025-08-31 | K Shares | MIDKX | 4,662 | 316,736.28 | 0.293 |
| SHELTON FUNDS | 2025-08-31 | Investor Shares | SPMIX | 4,662 | 316,736.28 | 0.293 |
| Global X Funds | 2025-08-31 | Global X HealthTech ETF | HEAL | 29,358 | 1,994,582.52 | 4.4615 |
| ETF Series Solutions | 2025-08-31 | Vident U.S. Equity Strategy ETF | VUSE | 22,000 | 1,494,680 | 0.2125 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 2025-08-31 | SIIT Multi-Asset Real Return Fund - Class A | SEIAX | 796 | 54,080.24 | 0.0071 |